Pulmonary surfactant proteins A and D: Innate immune functions and biomarkers for lung diseases

Current Pharmaceutical Design

Volumn 12, Issue 5, 2006, Pages 589-598

  Takahashi, Hiroki ^a   Sano, Hitomi ^a,b   Chiba, Hirofumi ^a   Kuroki, Yoshio ^a,b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Biomarker; Inflammation; Innate immunity; Interstitial lung disease; Pulmonary collectin; SP A; SP D; Surfactant

Indexed keywords

BIOLOGICAL MARKER; CALRETICULIN; CD14 ANTIGEN; COLLECTIN; MANNOSE RECEPTOR; OPSONIN; REGULATOR PROTEIN; SCAVENGER RECEPTOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; TOLL LIKE RECEPTOR; SURFACTANT PROTEIN B;

ADULT RESPIRATORY DISTRESS SYNDROME; AMNION FLUID; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; COLLAGEN DISEASE; COMPLEX FORMATION; EXHALATION; FETUS LUNG MATURITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS PROTEINOSIS; LUNG COLLAPSE; LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; MACROPHAGE; MICROORGANISM; NONHUMAN; PHAGOCYTOSIS; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RADIATION PNEUMONIA; REVIEW; ANIMAL; CHEMISTRY; IMMUNOLOGY; METABOLISM;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; LUNG DISEASES; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B;

EID: 33644891023     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206775474387     Document Type: Review

References (97)

1. King RJ, Clements JA. Surface active materials from dog lung. I. Method of isolation. Am J Physiol 1972; 223: 707-14.
2. Kuroki Y, Voelker DR. Pulmonary surfactant proteins. J Biol Chem 1994; 269: 25943-6.
3. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant protein D in heath and disease. Am J Physiol 1998; 275: L1-L13.
4. Nogee LM, DeMello DE, Delmer LP, Colten HR. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Eng J Med 1993; 328: 406-10.
5. Day AJ. The C-type carbohydrate recognition domain (CRD) superfamily. Biochem Soc Trans 1994; 22: 83-8.
6. Inoue T, Matsuura E, Nagata A, Ogasawara Y, Hattori A, Kuroki Y, et al. Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D. J Immunol Methods 1994; 173: 157-64.
7. Kuroki Y, Fukada Y, Takahashi H, Akino T. Monoclonal antibodies against human pulmonary surfactant apoproteins: specificity and application in immunoassay. Biochim Biophys Acta 1985; 836: 201-9.
8. Haagsman HP, Hawgood S, Sargeant T, Buckley D, White RT, Drickamer K, et al. The Major Lung Surfactan Protein, SP 28-36, Is a Calcium-dependent Carbohydrate-binding Protein. J Biol Chem 1987; 262: 13877-80.
9. Persson A, Chang D, Crouch E. Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. J Biol Chem 1990; 265: 5755-60.
10. Kuroki Y, Akino T. Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine. J Biol Chem 1991; 266: 3068-73.
11. Childs RA, Wright JR, Ross GF, Yuen C-T, Lawson AM, Chai W, et al. Specificity of Lung Surfactant Protein SP-A for both the carbohydrate and the lipid moieties of certain neutral glycolipids. J Biol Chem 1992; 267: 9972-9.
12. M2. Arch Biochem Biophys 1992: 299: 261-7.
13. Suzuki Y, Fujita Y, Kogishi K. Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989; 140: 75-81.
14. Dobbs LG, Wright JR, Hawgood S, Gonzalez R, Venstrom K, Nellenbogen J. Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells. Proc Natl Acad Sci USA 1987; 84: 1010-4.
15. Kuroki Y, Mason RJ, Voelker DR. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 1988; 263: 3388-94.
16. Kuroki Y, Mason RJ, Voelker DR. Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein A. Proc Natl Acad Sci USA 1988; 85: 5566-70.
17. Wright JR, Wager RE, Hawgood S, Dobbs L, Clements JA. Surfactant apoprotein Mr = 26, 000-36, 000 enhances uptake of liposomes by type II cells. J Biol Chem 1987; 262: 2888-94.
18. Kuroki Y, Gasa S, Ogasawara Y, Shiratori M, Makita A, Akino T. Binding specificity of lung surfactant protein SP-D for glucosylceramide. Biochem Biophys Res Commun 1992, 187: 963-9.
19. Ogasawara Y, Kuroki Y, Akino T. Pulmonary surfactant protein D specifically binds to phosphatidylinositol. J Biol Chem 1992; 267: 21244-9.
20. Persson AV, Gibbons BJ, Shoemaker JD, Moxley MA, Longmore WJ. The major glycolipid recognized by SP-D in surfactant is phosphatidylinositol. Biochemistry 1992; 31: 12183-9.
21. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998; 19: 177-201.
22. Lawson PR, Reid KB, M. The roles of surfactant proteins A and D in innate immunity. Immunol Rev 2000; 173: 66-78.
23. Kabha K, Schmegner J, Keisari Y, Parolis H, Schlepper-Schaefer J, Ofek I. SP-A enhances phagocytosis of Klebsiella by interaction with capsular polysaccharides and alveolar macrophages. Am J Physiol 1997; 272: L344-L52.
24. Sidobre S, Nigou J, Puzo G, Riviere M. Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to Mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition. J Biol Chem 2000; 275: 2415-22.
25. Kudo Y, Sano H, Takahashi H, Kuronuma K, Yokota S, Fujii N, et al. Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J Immumol 2004; 172: 7592-602.
26. McNeely TB, Coonrod JD. Aggregation and opsonization of type A but not type B Hemophilus influenzae by surfactant protein A. Am J Respir Cell Mol Biol 1994; 11: 114-22.
27. Zimmerman PE, Voelker DR, McCormack FX, Paulsrud JR, Martin WJI. 120 kDa surface glycoprotein of Pneumocystis-carinii is a ligand for surfactant protein A. J Clin Invest 1992; 89: 143-9.
28. Kuan S-F, Rust K, Crouch E. Interaction of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia Coli-binding protein in bronchoalveolar lavage. J Clin Invest 1992; 90: 97-106.
29. Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytsosis of the bacteria by macropahges. J Immunol 1999; 163: 312-21.
30. Chiba H, Pattanajitvilai S, Evans AJ, Harbeck RJ, Voelker DR. Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids. J Biol Chem 2002; 277: 20379-85.
31. Sano H, Nagai K, Tsutsumi H, Kuroki Y. lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur J Immunol 2003; 33: 2894-902.
32. van Iwaarden F, Welmers B, Verhoef J, Haagsman HP, van Golde LMG. Pulmonary surfactant protein A enhances the host-defence mechanism of rat alveolar macrophages. Am J Respir Cell Mol Biol 1990; 2: 91-8.
33. van Iwaarden JF, van Strijp JAG, Ebskamp MJM, Welmers AC, Verhoef J, van Golde LMG. Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages, Am J Physiol 1991; 261: L204-L9.
34. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003; 111: 1589-602.
35. Cormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS Jr. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003; 278: 36250-6.
36. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997; 158: 4336-40.
37. LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TM. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998; 19: 700-8.
38. LeVine AM, Whitsett JA, Gwozdz JA, Richradson TR, Fisher JH, Burhans MS, et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165: 3934-40.
39. Linke MJ, Harris CE, Korfhagen TR, McCormack FX, Ashbaugh AD, Steele P, et al. Immunosuppresive surfactant protein A-deficient mice have increased susceptibility to Pneumocyctis carinii infection. J Infect Dis 2001; 183: 943-52.
40. Borron P, McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J, Wright JR. Surfactant associated protein-A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol (Lung Cell Mol Physiol) 2000; 278: L840-7.
41. Botas C, Polain F, Akiyama J, Brown C, Allen L, Goerke J, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998, 95:11869-74.
42. Korfhagen TR, Sheftelyevich V, Burhans MS, Bruno MD, Ross GF, Wert SE, et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998; 273: 28438-43.
43. Wert SE, Yoshida M, LeVine AM, Ikegami M, Jones T, Ross GF, et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 2000; 97: 5972-7.
44. LeVine AM, Whitsett J, Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol. 2001; 167: 5868-73.
45. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate-immune response. Nature 2000; 406: 782-7.
46. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Toll-Like Receptor 4 (TLR4)-Deficient Mice Are Hyporesponsive to Lipopolysaccharide: Evidence for TLR4 as the Lps Gene Product J Immunol 1999; 162: 3749-52.
47. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gramnegative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443-51.
48. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, et al. The toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401: 811-5.
49. Shimazu R, Akahsi S, Ogata H, Nagai Y, Fukudome K, Miyake K, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999, 189: 1777-82.
50. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. J Biol Chem 2001; 276: 21129-35.
51. Sano H, Sohma H, Muta T, Nomura S, Voelker DR, Kurokii Y. Pulmonary surfactant protein A modulates the cellular responses to smooth and rough lipopolysaccharides by interactions with CD14. J Immunol 1999; 163:387-95.
52. Chiba H, Sano H, Iwaki D, Murakami S, Mutsuzawa H, Takahashi T, et al. Rat mannose-binding protein A binds CD 14. Infect Immun 2001; 69: 1587-92.
53. Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 2000; 275: 22442-51.
54. Griffis JM, Schneider H, Mandrell RE, Yamasald R, Jarvis AG, Kim JJ, et al. Lipopolysaccharides: the principal glycolipids of neisserial outer membrane. Rev Infect Dis 1988; 10 (suppl): S287-S95.
55. Murakami S, Iwaki D, Mitsuzawa H, Sano H, Takahashi H, Voelker DR, et al. Surfactant protein A inhibits peptidoglycaninduced tumor necrosis factor-α secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2. J Biol Chem 2002, 277: 6830-7.
56. Sato M, Sano H, Iwaki D, Kudo K, Konishi M, Takahashi H, et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosaninduced NF-κB activation and TNF-secretion are down-regulated by lung collectin surfactant protein A. J Immunol 2003; 171: 417-25.
57. Gardai SJ, Xiao Y-Q, Dickinson M, Nick JA, Voelker DR, Greene KE, et al. By binding SIRPa or calreticulin/CD91, lung collectin act as dual function surveillance molecules to supress or enhance inflammation. Cell 2003; 115: 13-23.
58. Geertsma MF, Nibbering PH, Haagsman HIP, Daha MR, Van Furth R. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes. Am J Physiol 1994; 267: L578-L84.
59. Hartshorn KL, Crouch E, White MR, Colamussi ML, Kakkanatt A, Tauber B, et al. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998; 274: L958-L69.
60. Tino MJ, Wright JR. Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages. Am J Physiol 1996; 270: L677-L88.
61. Tenner AJ, Robinson SL, Borchelt J, Wright JR. Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem 1989, 264: 13923-8.
62. Kuronuma K, Sano H, Kato K, Kudo K, Hyakushima N, Yokota S, et al. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J Biol Chem 2004; 279: 21421-30.
63. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995; 155: 5343-51.
64. Weikert LF, Edwards K, Chroneos ZC, hager C, Hoffman L, Shepherd VL. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am J Physiol 1997; 272: L989-L95.
65. Beharka AA, Gaynor CD, Kang BK, Voelker DR, McCormack FX, et al. Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages. J Immunol 2002; 169: 3565-673.
66. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17: 593.
67. Downing JF, Pasula R, Wright JR, Twigg III HL, Martin II WJ. Surfactant protein A promotes attachment of mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci USA 1995; 92: 4848.
68. Schagat TL, Wofford JA, Wright JR. Surfactant protein A enhances alveolar macrophages phagocytosis of apoptotic neutrophils. J Immunol 2001; 166:2727-33.
69. Vandivier RW, Ogden CA, Fadok VA, Hoffman PR, Brown KK, Botto M, et al. Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol 2002; 169: 3978-86.
70. Chiba H, Sano H, Saitoh M, Sohma H, Voelker DR, Akino T, et al. Introduction of mannose-binding protein-type phosphatidylinositol recognition into pulmonary surfactant protein A. Biochemistry 1999; 38: 7321-31.
71. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995; 152: 1860-6.
72. Kuroki Y, Tsutahara S, Shijubo N, Takahashi H, Shiratori M, Hattori A, et al. Elevated levels of lung surfactant protein A in sera from patients with idiopathic pulmonary fibrosis and pulmonary alveolar proteinosis. Am Rev Respir Dis 1993; 147: 723-9.
73. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-42.
74. Honda Y, Takahashi H, Shijubo N, Kuroki Y, Akino T. Surfactant protein-A in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993; 103: 496-9.
75. McCormack FX, King JTE, Voelker DR, Robinson PC, Mason RJ. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am Rev Respir Dis 1991; 144: 160-6.
76. Honda Y, Tsunematu K, Suzuki A, Akino T. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Lung 1988; 166: 293-301.
77. McCormack FX, King TE, Bucher BL, Nielsen L, Mason RJ. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995; 152: 751-9.
78. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler III AA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991; 88: 1976-81.
79. Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999; 160: 1843-50.
80. Mizutani Y, Nakajima T, Morinaga. S, Gotah M, Shimosato Y, Akino T, et al. Immunohistochemical Localization of pulmonary surfactant apoproteins in various lung tumors. Special references to nonmucus producing lung adenocarcinomas. Cancer 1988, 61: 532-7.
81. Shijubo S, Tautahara S, Hirasawa. M, Takahash H, Honda Y, Suzuki A, et al. Pulmonary surfactant protein A in pleural effusions. Cancer 1992; 69: 2905-9.
82. Kuroki Y, Takahashi H, Fukada Y, Mikawa M, Inagawa A, Fujimoto S, et al. Two-site "simultaneous" immunoassay with monoclonal antibodies for the determination of the surfactant apoproteins in human amniotic fluid. Pediatr Res 1985, 19: 1017-20.
83. Hallman M, Arjomaa P, Mizumoto M, Akino T. Surfactant proteins in the diagnosis of fetal lung maturity. I. Predictive accuracy of the 35 kd protein, the lecithin/sphingomyelin ratio, and phosphatidylglycerol. Am J Obstet Gynecol 1988; 158: 531-5.
84. Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, et al. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 2000; 162: 258-63.
85. Honda Y, Kuroki Y, Shijubo N, Fujishima T, Takahashi H, Hosoda K, et al. Aberrant appearance of lung surfactant protein A in sera of patients with idiopathic pulmonary fibrosis and its clinical significance. Respiration 1995; 62: 64-9.
86. Kida K, Oda H, Yamano Y, Kagawa J. Effects of cigarette smoking on the serum concentration of lung surfactant protein A (SP-A). Eur Respir J 1997; 10: 2124-6.
87. 1)2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin Chim Acta 1997; 266: 157-71.
88. Greene KE, King TE, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, el al. Serum surfactant protein-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 2002; 19: 439-46.
89. Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and teir relationship to disease extent. Am J Respir Crit Care Med 2000; 162: 1109-14.
90. Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, et al. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum 2001; 44: 1363-9.
91. Takahashi H, Honda Y, Kuroki Y, Imai K, Abe S. Pulmonary surfactant protein A: a serum marker of pulmonary fibrosis in patients with collagen vascular diseases. Clin Chem Acta 1995; 239: 213-5.
92. Sasaki R, Soejima T, Matsumoto A, Murata T, Yamada K, Ota Y, et al. Clinical significance of serum pulmonary surfactant proteins A and D for the early detection of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2001; 50: 301-7.
93. Takahashi H, Imai Y, Fujishima T, Shiratori M, Murakami S, Chiba H, et al. Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis. Eur Respir J 2001; 17: 481-7.
94. Hallman M, Maasila P, Kivisaari L, Mattson K. Changes in surfactant in bronchoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma. Am Rev Respir Dis 1990; 141: 998-1005.
95. Kelly M, Kolb M, Bonniaud P, Gauldie J. Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Design 2003; 9(1): 39-49.
96. Marshall RP. The pulmonary renin-angiotensin system. Curr Pharm Design 2003; 9(9): 715-22.
97. Tsai WC, Standiford TJ. Immunomodulatory effects of macrolides in the lung: lessons from in-vitro and in-vivo models. Curr Pharm Design 2004; 10(25): 3081-93.